Abstract
The aim of this study was to survey Cdx2 expression in pyloric gland adenoma (PGA) of the gallbladder. We reviewed 29 PGA cases, ten (34.4%) and seven (24.1%) of which showed intestinal metaplasia (IM) and squamous morule (SM), respectively. The immunostaining for Cdx2, beta-catenin, MUC5AC, MUC2, MUC6, and M-GGMC-1 was performed and scored (0 = negative, 1+ = <10%, 2+ = 10% to <30%, 3+ = 30% to <50%, 4+ = 50% to <70%, 5+ = 70–100%). Although its scores were relatively low (1+ or 2+), Cdx2 was frequently expressed in 27 cases (93.1%). Not only goblet and/or Paneth cells were positive but also non-IM cells in PGAs, as opposed to the lack of staining in the background mucosa. Cdx2 scores were not correlated with those of IM (p = 0.485) and MUC2 (p = 0.868). Of note, Cdx2 was positive in foci of SM in all seven cases, and there was a significant difference in Cdx2 scores between PGAs with and without SM. Furthermore, the p value of scores between Cdx2 and beta-catenin was 0.051, and both mean labeling indices (LIs) were correlated (r = 0.736). With Cdx2, higher morular LIs than glandular LIs were observed (p = 0.001). Finally, we concluded that aberrant Cdx2 expression in PGAs is closely associated with nuclear beta-catenin expression and SM in contrast with IM.
Similar content being viewed by others
References
Suh E, Chen L, Taylor J et al (1994) A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 14:7340–51
Barbareschi M, Murer B, Colby TV et al (2003) Cdx2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol 27:141–9
Silberg DG, Swain GP, Suh ER et al (2000) Cdx1 and Cdx2 expression during intestinal development. Gasteroenterology 119:961–71
Werling RW, Yaziji H, Bacchi CE et al (2003) CDX2, a highly sensitive and specific marker of adenocarcinoma of intestinal origin. Am J Surg Pathol 27:303–10
De Lott L, Morrison C, Suster S et al (2005) Cdx2 is a useful marker of intestinal-type differentiation. Arch Pathol Lab Med 129:1100–5
Kaimaktchiev V, Terracciano L, Tornillo L et al (2004) The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 17:1392–9
Mazziotta R, Borczuk A, Powell C et al (2005) CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol 12:55–60
Moskaluk CA, Zhang H, Powell SM et al (2003) Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 16:913–9
Chang YT, Hsu C, Jeng YM et al (2007) Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma. J Gastroenterol Hepatol 22:389–4
Osawa H, Kita H, Satoh K et al (2004) Aberrant expression of CDX2 in the metaplastic epithelium and inflammatory mucosa of the gallbladder. Am J Surg Pathol 28:1253–4
Sakamoto H, Mutoh H, Ido K et al (2007) A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis. Hum Pathol 38:66–71
Wu XS, Akiyama Y, Igari T et al (2005) Expression of homeodomain protein CDX2 in gallbladder carcinomas. J Cancer Res Clin Oncol 131:271–8
Nagata S, Ajioka Y, Nishikura K et al (2007) Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10. Oncol Rep 17:721–9
Wani Y, Notohara K, Saegusa M et al (2008) Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Hum Pathol 39:1072–9
Saegusa M, Hashimura M, Kuwata T et al (2007) Functional role of Cdx2 in beta-catenin signaling during transdifferentiation in endometrial carcinomas. Carcinogenesis 28:1885–92
Takei K, Watanabe H, Itoi T, Saito T (1996) p53 and Ki-67 immunoreactivity and nuclear morphometry of ‘carcinoma-in-adenoma’ and adenoma of the gall-bladder. Pathol Int 46:908–17
Crum C, Lee K (2005) Diagnostic gynecologic and obstetric pathology. Elsevier, Philadelphia, pp 525–529, 553–558
Nakatani Y, Masudo K, Nozawa A et al (2004) Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression. Hum Pathol 35:869–74
Saegusa M, Okayasu I (2001) Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 194:59–67
Gamachi A, Kashima K, Daa T et al (2003) Aberrant intranuclear localization of biotin, biotin-binding enzymes, and beta-catenin in pregnancy-related endometrium and morule-associated neoplastic lesions. Mod Pathol 16:1124–31
Saegusa M, Hashimura M, Kuwata T et al (2004) β-catenin simultaneously induces activation of the p53-p21WAF-1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 164:1739–1749
Chang HJ, Jee CD, Kim WH (2002) Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 26:758–66
Yanagisawa N, Mikami T, Saegusa M et al (2001) More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 61:19–22
Acknowledgements
The authors thank Mr. Hironori Kajitani and Ms. Akemi Minamimoto for their technical support. They also thank Mr. Yoshiharu Yamamoto, Clinical Research Center, Kurashiki Central Hospital, for providing assistance with the statistical analyses.
Disclosure/Conflict of Interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wani, Y., Notohara, K. & Fujisawa, M. Aberrant expression of an “intestinal marker” Cdx2 in pyloric gland adenoma of the gallbladder. Virchows Arch 453, 521–527 (2008). https://doi.org/10.1007/s00428-008-0680-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-008-0680-z